跳至主要内容
临床试验/NL-OMON40081
NL-OMON40081已完成2 期

Sentinel Node Biopsy using Magnetic Nanoparticles: A prospective multicentre phase II non-randomised clinical trial to compare sentinel node biopsy using magnetic nanoparticles vs. standard technique - SentiMag Multicentre Trial

King's College London0 个研究点目标入组 75 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
75

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Patients with breast cancer scheduled for SLNB and who are clinically and radiologically (pre-operative ultrasound normal or indeterminate/abnormal and benign FNA or core biopsy) node negative;Patients available for follow-up for at least 12 months

排除标准

  • Intolerance / hypersensitivity to iron or dextran compounds or Sienna+;Patients who cannot / do not receive radioisotope for SLNB;Patients with an iron overload disease;Patients with pacemakers or other implantable devices in the chest-wall;Intolerance / hypersensitivity to patent blue dye in centres where this is used routinely;Exlusion criteria MRI-subprotocol:;Presence of implantable devices (electronically, magnetically, mechanically activated. E.g: cardioverter defibrillators, cardiac pacemakers);Metallic splinters in the eye;Ferromagnetic haemostatic clips in the central nervous system;Claustrophobia

研究者

相似试验

Sentinel Node Biopsy using Magnetic Nanoparticles: A... | 临床试验